{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-000916","form_type":"8-K","ticker":"INKT","cik":"0001840229","company_name":"MiNK Therapeutics, Inc.","filed_at":"2026-01-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.481123+00:00","generated_at":"2026-05-16T11:49:41.503322+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Director Robert Kadlec resigns from MiNK Therapeutics board for U.S. government role","bullets":["Robert Kadlec, MD, resigned from the Board of Directors effective December 29, 2025.","Resignation due to acceptance of senior public service role as Assistant Secretary of War for Nuclear Deterrence and Chemical and Biological Defense Policy and Programs.","Dr. Kadlec joined the Board in October 2024; no replacement announced.","Company expressed appreciation for his service and perspective."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-000916","json":"https://secwatch.observer/filing/0001193125-26-000916.json","markdown":"https://secwatch.observer/filing/0001193125-26-000916.md","text":"https://secwatch.observer/filing/0001193125-26-000916.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526000916/0001193125-26-000916-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526000916/inkt-20251229.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:49:41.503322+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}